Correction: Making scientific publishing more balanced and reversing the current dangerous drift to better support global environmental conservation and planetary health. [PDF]
Guidetti P +4 more
europepmc +1 more source
ABSTRACT Background Secretory phospholipase A2 (sPLA2) is an inflammatory mediator linked to acute chest syndrome (ACS) in sickle cell disease (SCD), a serious complication that can develop during an acute vaso‐occlusive pain episode (VOE). Plasma sPLA2 levels have been proposed as a potential biomarker for predicting ACS onset.
Rawan Korman +10 more
wiley +1 more source
A responsible authorship culture is needed and it is a collective responsibility. [PDF]
Kiermer V, Bibbins-Domingo K, Skipper M.
europepmc +2 more sources
Reassessing the evidence linking clinical leadership to AI deployment outcomes. [PDF]
Bair H.
europepmc +1 more source
ABSTRACT Background Japan's 2024 physician work‐style reform introduced legally binding limits on physicians’ working hours, but its impact on education and workforce sustainability in pediatric hematology–oncology (PHO) remains unclear. Procedure We conducted a repeated cross‐sectional study with structured quantitative items and free‐text responses ...
Kiyohiko Kaizu +7 more
wiley +1 more source
Re-examining equity in urology Evaluating the emergence of unintended bias against male clinicians and academics. [PDF]
Khan MZ, Ismail A, Kotb A.
europepmc +1 more source
A Bibliometric Analysis of Publications in Uremic Toxins From 1991 to 2024
ABSTRACT Background Uremic toxins are a growing area of research in nephrology, with significant implications in the progression and treatment of chronic kidney disease (CKD) and the management of end‐stage kidney disease (ESKD). This bibliometric analysis aims to evaluate the global research trends, key contributors, and the impact of publications in ...
Yuh‐Shan Ho +7 more
wiley +1 more source
Retraction Note: Exploration of the clinicopathological and prognostic significance of BRCA1 in gastric cancer. [PDF]
Zhang H, Xu Q, Kan H, Yang Y, Cai Y.
europepmc +1 more source
ABSTRACT Background Therapeutic apheresis (TA) is an established treatment modality for hematologic, neurologic, and immunologic disorders, yet access remains severely limited in sub‐Saharan Africa. Donor apheresis, including platelet apheresis collection from healthy donors, represents an important complementary modality supporting blood product ...
Nosa Bazuaye +33 more
wiley +1 more source
Journal of Global Health's GUidelines for Authors on Requesting and DIsclosing changes in Authorship Nominations (GUARDIAN). [PDF]
Ursić L, Campbell H, Rudan I.
europepmc +1 more source

